CIK 0001801170
- Large accelerated filer
CLOVER HEALTH INVESTMENTS, CORP. /DE
Sign in to watch- Ticker
- CLOV
- Exchange
- Nasdaq
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 981515192
- Phone
- +1 201-432-2133
- Business address
- 30 MONTGOMERY STREET, JERSEY CITY, NJ, 07302
- Former names
- Social Capital Hedosophia Holdings Corp. III
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,688,461
- in 16 filings, $3.6M under 10b5-1 plans
Net −$3,688,461. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Toy Andrew −$1.6M Chief Executive Officer sold 4% of stake
- Wai Conrad −$1.5M CEO, Counterpart Health sold 24% of stake
- Reynoso Jamie L. −$204K CEO, Medicare Advantage sold 2% of stake
- Soares Karen −$191K Chief Legal Officer sold 3% of stake
- OLDAKOWSKI JOSEPH FRANK −$118K VP OF FINANCE AND CONTROLLER sold 8% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-07 | Garipalli Vivek Director | Option exercise | +1,655,949 | 3,512,196 | ||
| 2026-01-07 | Garipalli Vivek Director | Shares withheld for taxes | −1,655,949 | $2.59 | $4.3M | 1,856,247 |
| 2026-01-07 | Garipalli Vivek Director | Option exercise · Restricted Stock Unit | −3,342,699 | 0 | ||
| 2026-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | +3,342,699 | 10,247,042 | ||
| 2026-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | −1,655,949 | 8,591,093 | ||
| 2025-08-08 | Garipalli Vivek Director | Purchase | +31,980 | $2.17 | $69K | 1,856,247 |
| 2025-08-07 | Garipalli Vivek Director | Purchase | +415,000 | $2.24 | $930K | 1,824,267 |
| 2025-01-07 | Garipalli Vivek Director | Option exercise | +1,670,965 | 3,080,232 | ||
| 2025-01-07 | Garipalli Vivek Director | Shares withheld for taxes | −1,670,965 | $3.60 | $6.0M | 1,409,267 |
| 2025-01-07 | Garipalli Vivek Director | Option exercise · Restricted Stock Unit | −3,342,698 | 3,342,699 | ||
| 2025-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | +3,342,698 | 8,575,308 | ||
| 2025-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | −1,670,965 | 6,904,343 | ||
| 2024-08-09 | Garipalli Vivek Director | Purchase | +531,700 | $1.88 | $1000K | 1,409,267 |
| 2024-06-17 | Garipalli Vivek Director | Purchase | +877,567 | $1.14 | $1.0M | 877,567 |
| 2024-01-07 | Garipalli Vivek Director | Option exercise | +1,561,065 | 1,561,065 | ||
| 2024-01-07 | Garipalli Vivek Director | Shares withheld for taxes | −1,561,065 | $0.95 | $1.5M | 0 |
| 2024-01-07 | Garipalli Vivek Director | Option exercise · Restricted Stock Unit | −3,342,698 | 6,685,397 | ||
| 2024-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | +3,342,698 | 6,793,675 | ||
| 2024-01-07 | Garipalli Vivek Director | Option exercise · Class B Common Stock | −1,561,065 | 5,232,610 | ||
| 2023-01-07 | Garipalli Vivek Executive Chairperson | Option exercise | +1,569,594 | 1,569,594 |
Page 1 of 2 · 34 trades